Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Satellos Bioscience Inc (MSLE)

29 + Investors. Track Smart Money conviction in MSLE. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
1Q ▲
Buyers last Q
48%

Smart Money Signals — MSLE

Based on 29 hedge funds · latest filing: 2026 Q3 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 2Q
For 1 consecutive quarter, more hedge funds added MSLE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (97% of max)

97% of all-time peak
29 hedge funds hold MSLE right now — the highest count in 0.8 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🟠

More sellers than buyers — 48% buying

11 buying12 selling
Last quarter: 12 funds reduced or exited vs 11 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~6 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 3 → 6. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 100% entered in last year

■ 0% conviction (2yr+) ■ 0% medium ■ 100% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new
Of 29 current holders: 29 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds
9 of 29 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.4
out of 10
Moderate Exit Risk
Exit risk score 5.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — MSLE

In 2026 Q3, 11 hedge funds were net buyers of MSLE (6 opened a new position, 5 added to an existing one), while 12 reduced or exited (9 trimmed, 3 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 29.

Hedge Fund Ownership: MSLE

How many hedge funds hold MSLE — quarterly history vs. share price
Quarterly hedge fund ownership of MSLE vs. share price

Market Analysis: MSLE

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: MSLE

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Satellos Bioscience Inc (MSLE) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much MSLE has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 50d ago
MSLE
-27.1%
XLV
+7.6%

MSLE outperformed XLV by -34.7% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 5d ago
MSLE
-6.3%
XLV
-4.1%

Since the filing became public, MSLE outperformed XLV by -2.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

3 top-rated funds 0 high-conviction
Consensus
2.6
/ 10
breadth
×
Elite
1.1
/ 10
conviction
Hedge Fund Positioning: MSLE
29 + Investors

Track Smart Money conviction in MSLE. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q3) Prior (2026 Q2) Change
Funds Holding 29 26 11.54%
13F Shares 8M 8M -1.31%
Total Value $63M $60M 5.01%
New Positions 6 3 +3
Increased Positions 5 6 -1
Closed Positions 3 7 -4
Reduced Positions 9 6 +3
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: MSLE

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

29 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MSLE. Verified SEC 13F-HR filings.

QUARTER:
Top 25 MSLE holders by conviction (% of portfolio weight) — 2026 Q3 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Stonepine Capital Management, LLC 2.43% 455,058 $3.9M
2 Sphera Funds Management LTD. 0.77% 638,690 $5.4M
3 Vivo Capital, LLC 0.76% 813,666 $6.9M
4 Saturn V Capital Management LP 0.64% 516,800 $4.4M
5 Empery Asset Management, LP 0.51% 58,000 $493K
6 Crcm LP 0.32% 68,060 $579K
7 Avidity Partners Management LP 0.29% 164,019 $1.4M
8 Siren, L.L.C. 0.18% 892,074 $7.6M
9 AWM Investment Company, Inc. 0.15% 180,000 $1.5M
10 683 Capital Management, LLC 0.13% 355,000 $3.0M
11 Soleus Capital Management, L.P. 0.10% 330,102 $2.8M
12 Montanova Capital, LLC 0.09% 475,000 $4.0M
13 Woodline Partners LP 0.01% 500,432 $4.3M
14 Point72 Asset Management, L.P. 0.01% 681,800 $5.8M
15 China Universal Asset Management Co., Ltd. 0.01% 12,800 $110K
16 Quadrature Capital Ltd 0.00% 38,916 $331K
17 Franklin Templeton Inc 0.00% 938,666 $6.1M
18 Adage Capital Partners GP, L.L.C. 0.00% 100,000 $850K
19 Millennium Management LLC 0.00% 253,796 $2.2M
20 Provenance Wealth Advisors, LLC 0.00% 83 —
21 Citadel Advisors LLC 0.00% 43,190 $367K
22 Royal Bank of Canada 0.00% 15,863 $124K
23 Jane Street Group, LLC 0.00% 21,417 $182K
24 Morgan Stanley 0.00% 11,862 $101K
25 BNP Paribas Financial Markets 0.00% 1,056 $9K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Satellos Bioscience Inc (MSLE)

What does the Smart Money Trend signal show for MSLE?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added MSLE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for MSLE?

More sellers than buyers — 48% buying: Last quarter: 12 funds reduced or exited vs 11 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for MSLE holders?

Smaller funds dominant — 15% AUM from top-100: 9 of 29 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held MSLE?

Mostly new holders — 100% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Satellos Bioscience Inc (MSLE) following the 2026 Q3 hedge fund 13F filings?

As of today, MSLE has moved -6.3% since the 2026 Q3 13F filing date (November 14, 2026), compared to -4.1% for the XLV sector ETF — an outperformance of -2.2%. Since the quarter end (September 30, 2026), MSLE has gained -27.1% vs +7.6% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →